Other Streetwise ReportsThe Gold Report The Energy Report The Life Sciences Report The Mining Report
Today's Featured Company
Can-Fite BioPharma Ltd.: (CANF:NYSE.MKT) Can-Fite BioPharma Ltd. is an advanced clinical stage drug development company with a platform technology that addresses multibillion dollar markets in the treatment of cancer, inflammatory and other diseases. The completed its Phase 2/3 trials for psoriasis and is in Phase 2 trials for liver cancer. Study design for a Phase 3 trial in rheumatoid arthritis has been completed. More >
Streetwise Expert Interviews
Ran Nussbaum, managing partner with The Pontifax Group, doesn't worry too much about overall market volatility. Biotechs, he feels, are somewhat immune to turmoil because their fundamentals are based in real life. He prefers to play on good science and unmet medical needs, and then sit tight until a stock is discovered. In this interview with The Life Sciences Report, Nussbaum describes a few takeover candidates primed for stellar growth, as well as promising names that are part of the movement toward personalized medicine.(9/2/15) More >
Many novel ideas are now in the clinic, and have opened up fresh opportunities for dramatic industry growth, especially in the gene and cellular therapy realm. David Nierengarten of Wedbush Securities brings a handful of companies with technologies that could revolutionize medicine to investors' attention. (8/26/15) More >
Learn More About Companies in This Issue
|Alliance for Regenerative Medicine|
BrainStorm Cell Therapeutics Inc.
RepliCel Life Sciences Inc.
|Nobilis Health Corp.|
|Aethlon Medical Inc.|